One of two unstructured domains of Ii becomes ordered in complexes with MHC class II molecules

Immunity

Volumn 10, Issue 6, 1999, Pages 761-768

  Jasanoff, Alan ^a,c   Song, Soyoun ^a   Dinner, Aaron R ^a   Wagner, Gerhard ^b   Wiley, Don C ^a  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 0033152268     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80075-8     Document Type: Article

References (40)

1. Avva, R.R., and Cresswell, P. (1994). In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1, 763-774.
2. Bakke, O., and Dobberstein, B. (1990). MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.
3. Bevec, T., Stoka, V., Pungercic, G., Dolenc, I., and Turk, V. (1996). Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183, 1331-1338.
4. Bijlmakers, M.J., Benaroch, P., and Ploegh, H.L. (1994). Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180, 623-629.
5. Blum, J.S., and Cresswell, P. (1988). Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85, 3975-3979.
6. Creighton, T.E. (1993). Proteins: Structures and Molecular Properties (Freeman: New York).
7. Cresswell, P. (1985). Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 82, 8188-8192.
8. Demotz, S., Danieli, C., Wallny, H.J., and Majdic, O. (1994). Inhibition of peptide binding to DR molecules by a leupeptin-induced invariant chain fragment. Mol. Immunol. 31, 885-893.
9. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
10. 15N NMR relaxation. Biochemistry 33, 5984-6003.
11. Freisewinkel, I.M., Schenck, K., and Koch, N. (1993). The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 90, 9703-9706.
12. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
13. Jasanoff, A., Park, S.-J., and Wiley, D.C. (1995). Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain. Proc. Natl. Acad. Sci. USA 92, 9900-9904.
14. Jasanoff, A., Wagner, G., and Wiley, D.C. (1998). Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein II. EMBO J. 17, 6812-6818.
15. Kampgen, E., Koch, N., Koch, F., Stoger, P., Heufler, C., Schuler, G., and Romani, N. (1991). Class II major histocompatibility complex molecules of murine dendritic cells: Synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 88, 3014-3018.
16. Koch, N., Lauer, W., Habicht, J., and Dobberstein, B. (1987). Primary structure of the gene for the murine la antigen-associated invariant chains (li): An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6, 1677-1683.
17. Kraulis, P. (1991). Molscript, a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
18. Kropshofer, H., Vogt, A.B., Stern, L.J., and Hämmerling, G.J. (1995). Self-release of CLIP in peptide loading of HLA-DR molecules. Science 270, 1357-1359.
19. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V., and Peterson, P.A. (1990). Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
20. Machamer, C.E., and Cresswell, P. (1982). Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J. Immunol. 129, 2564-2569.
21. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: Critical role in li degradation and CD4 T cell selection in the thymus. Science 280, 450-453.
22. Neefjes, J.J., Stollorz, V., Peters, P.J., Geuze, H.J., and Ploegh, H.L. (1990). The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61, 171-183.
23. Newcomb, J.R., Carboy-Newcomb, C., and Cresswell, P. (1996). Trimeric interactions of the invariant chain and its association with major histocompatibility complex class II αβ dimers. J. Biol. Chem. 271, 24249-24256.
24. Park, S.-J., Sadegh-Nasseri, S., and Wiley, D.C. (1995). Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl. Acad. Sci. USA 92, 11289-11293.
25. 2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Seci USA 94, 12366-12371.
26. Pierre, P., and Mellman, I. (1998). Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93, 1135-1145.
27. Roche, P.A., Marks, M.S., and Cresswell, P. (1991). Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354, 392-394.
28. Romagnoli, P., and Germain, R.N. (1994). The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180, 1107-1113.
29. Sadegh-Nasseri, S., Stern, L.J., Wiley, D.C., and Germain, R.N. (1994). MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370, 647-650.
30. Sherman, M.A., Weber, D.A., and Jensen, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
31. Siebenkotten, I.M., Carstens, C., and Koch, N. (1998). Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J. Immunol. 160, 3355-3362.
32. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., MelLins, E., and Zaller, D.E. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
33. Stumptner, P., and Benaroch, P. (1997). Interaction of MHC class II molecules with the invariant chain: Role of the invariant chain (81-90) region. EMBO J. 16, 5807-5818.
34. Teyton, L., O'Sullivan, D., Dickson, P.W., Lotteau, V., Sette, A., Fink, P., and Peterson, P.A. (1990). Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348, 39-44.
35. Thayer, W.P., Ignatowicz, L., Weber, D.A., and Jensen, P.E. (1999). Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules. J. Immunol. 162, 1502-1509.
36. Vogt, A.B., Stern, L.J., Amshoff, C., Dobberstein, B., Hämmerling, G.J., and Kropshofer, H. (1995). Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155, 4757-4765.
37. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR 5, 67-81.
38. Witt, S.N., and McConnell, H.M. (1991). A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 88, 8164-8168.
39. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids (J. Wiley and Sons: New York).
40. Xia, T., and Bartels, C. (1994). XEASY User Manual (ETH-Hönggerberg: ZüRich).